Literature DB >> 30601184

Organ-sparing surgical and nonsurgical modalities in primary penile cancer treatment.

Yannic Raskin1, Joren Vanthoor1, Uros Milenkovic1, Asif Muneer2,3, Maarten Albersen1.   

Abstract

PURPOSE OF REVIEW: To provide an overview of the current state of literature on organ-sparing approaches in penile cancer. Surgical as well as nonsurgical approaches can be adapted in the right setting, in an effort to spare patients from the burden of total or subtotal penectomy wherever possible. In this review, we focus on surgical approaches. RECENT
FINDINGS: Narrower surgical margins do not seem to affect overall survival rates, neither do local recurrences. This has allowed a paradigm shift towards more sparing approaches locally. Contrary to what was previously thought, margins of a few millimetres suffice for adequate local cancer control. This allows laser therapy, wide local excisions, partial glansectomy and other surgical techniques to be performed in an organ-sparing fashion. Ablative techniques such as brachytherapy and external beam radiotherapy also provide adequate local cancer control. These sparing approaches have an important effect on psychological and functional outcomes; however, they are insufficiently adapted even in larger referral centres.
SUMMARY: Organ-sparing techniques should be used in penile cancer surgery whenever possible. Patient selection for the most appropriate technique is key to provide good cosmetic and functional results while remaining oncologically safe.

Entities:  

Mesh:

Year:  2019        PMID: 30601184     DOI: 10.1097/MOU.0000000000000587

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  7 in total

Review 1.  Making surgery safer by centralization of care: impact of case load in penile cancer.

Authors:  Joren Vanthoor; Anita Thomas; Igor Tsaur; Maarten Albersen
Journal:  World J Urol       Date:  2019-07-10       Impact factor: 4.226

Review 2.  Penile Cancer: Managing Sexual Dysfunction and Improving Quality of Life After Therapy.

Authors:  George Coba; Trushar Patel
Journal:  Curr Urol Rep       Date:  2021-01-09       Impact factor: 3.092

3.  Penile cancer: potential target for immunotherapy?

Authors:  Joren Vanthoor; Gigi Vos; Maarten Albersen
Journal:  World J Urol       Date:  2020-11-03       Impact factor: 4.226

Review 4.  Penile sparing therapy for penile cancer.

Authors:  Henry Han-I Yao; Shomik Sengupta; Justin Chee
Journal:  Transl Androl Urol       Date:  2020-12

Review 5.  Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis.

Authors:  Tynisha S Rafael; Jossie Rotman; Oscar R Brouwer; Henk G van der Poel; Constantijne H Mom; Gemma G Kenter; Tanja D de Gruijl; Ekaterina S Jordanova
Journal:  J Clin Med       Date:  2022-02-19       Impact factor: 4.241

6.  Disparities in Healthcare Access, Education, and Geographical Factors That Affect Surgical Outcomes in Penile Cancer.

Authors:  Juan Carlos Angulo-Lozano; Luisa Fernanda Sánchez Musi; Jose Garcia Garcia
Journal:  Cureus       Date:  2022-10-08

7.  Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000-2019.

Authors:  Sinja Kristiansen; Christian Torbrand; Åke Svensson; Ola Forslund; Carina Bjartling
Journal:  BJU Int       Date:  2022-01-24       Impact factor: 5.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.